retatrutide type 2 diabetes phase 2 trial obesity results 2024 ada demonstrate benefits of in obesity, diabetes, NASH Efficacy and Safety of Retatrutide Shows Strong Weight Loss

Available online: Accessed 20 March 2022 94 United States Department of Agriculture, Food Safety and Inspection Service

With digital health innovations, tools like a GLP-1 app are making it easier for patients to track doses, monitor progress, and stay on top of their therapy

This helps ensure that a greater proportion of the weight lost comes from fat, leading to a healthier, leaner body composition

Contact your GP if you experience: Persistent anxiety, panic attacks, or mood changes that interfere with daily functioning Physical symptoms accompanying anxiety, such as palpitations, chest tightness, breathlessness, or dizziness Neurological symptoms including numbness, tingling (paraesthesia), balance problems, or memory difficulties Symptoms that began shortly after starting B12 supplements or changing dosage Concerns about potential B12 deficiency (fatigue, pallor, glossitis, cognitive changes) Your GP can conduct a thorough assessment including medical history, medication review, and physical examination